SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-012335
Filing Date
2017-03-02
Accepted
2017-03-02 09:00:21
Documents
3
Period of Report
2017-02-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v460837_8k.htm 8-K 15606
2 EXHIBIT 99.1 v460837_ex99-1.htm EX-99.1 10886
3 GRAPHIC bcli_logo.jpg GRAPHIC 14515
  Complete submission text file 0001144204-17-012335.txt   48214
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36641 | Film No.: 17657080
SIC: 2836 Biological Products, (No Diagnostic Substances)